Clin2
NCT06363604Possibly a fitRecruiting

Alcohol injection with ablation for persistent atrial fibrillation

Atrial Fibrillation

Part of Heart & circulation clinical trials.

This trial is testing a new approach to treat persistent atrial fibrillation (a type of irregular heartbeat) by combining standard catheter ablation with a special injection of alcohol (ethanol) into certain heart veins. It may help people whose symptoms haven't improved with medication.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
260 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You are between 18 and 85 years old.
  • You have persistent atrial fibrillation (lasting at least 1 week) and at least one heart rhythm medication hasn't helped.
  • You are scheduled to have a standard catheter ablation for atrial fibrillation.
  • You have not had a prior catheter ablation or heart surgery for atrial fibrillation.
  • You have no recent heart attack, stroke, or severe heart failure, and no active cancer or bleeding disorder.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05427435Recruiting
Testing alcohol treatment of a heart vein during atrial fibrillation ablation

This study tests whether applying a small amount of alcohol to a specific heart vein (“vein of Marshall”) is safe and feasible during a standard atrial fibrillation (AF) ablation. It may help improve AF treatment, but the goal here is mainly to see if the approach can be done safely in the right patients.

Pessac
NCT07197931Not yet recruiting
Export trial: Ablation for persistent atrial fibrillation

This study tests a new approach to catheter ablation for people with persistent atrial fibrillation (a type of irregular heartbeat). It may be an option if you have not responded well to or could not tolerate a rhythm-control medication.

Seoul
NCT06402617Recruiting
Ablation of active spots in atrial fibrillation

This trial is testing a new way to treat atrial fibrillation by using a catheter to target the specific areas in the heart that trigger the irregular heartbeat. If you have persistent atrial fibrillation and haven't had prior catheter ablation, you may be eligible to join.

London
NCT04823299Recruiting
Atrial fibrillation ablation using two different energy types

This trial tests whether one ablation approach works better than another for paroxysmal (intermittent) atrial fibrillation by targeting the heart’s “triggers” and “substrate” (where the rhythm problem is). If you qualify, you’ll be randomly assigned to one of two ablation energy methods during a pulmonary vein isolation procedure.

Ottawa, Ontario
NCT06249347Recruiting
New ablation approach for persistent atrial fibrillation with stroke risk

This trial tests a new type of catheter ablation (using heat to create scar lines in the heart) for people with persistent atrial fibrillation who have a higher risk of stroke or bleeding. It aims to see if this approach can help prevent strokes and reduce the need for long-term blood thinners.

Wenzhou, Zhejiang
NCT07122336Recruiting
A better way to treat persistent atrial fibrillation

This trial tests a new method to treat persistent atrial fibrillation (a long-lasting irregular heartbeat) to see if it helps patients who haven't been helped by medication. It focuses on cleaning up the back wall of the heart to restore a normal rhythm.

Shanghai

Hear when a new Atrial fibrillation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.